Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis
Contributors: United States. Agency for Healthcare Research and Quality.
Series: Evidence report/technology assessment -- no. 89; AHRQ pub -- no. 04-E012-1; AHRQ publication -- no. 04-E 012-1.
Publisher: Agency for Healthcare Research and Quality
Published: 2004
Place of publication: [Rockville, Md.]
Language: eng
Format: Electronic resource
Subjects: Omega-3 fatty acids -- Therapeutic use.
Other titles: Effects of omega 3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis; Effects of omega-three fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis
Notes: Title from title screen (viewed on Apr. 24, 2004).

Mode of access: Internet from the AHRQ web site. Address as of 4/24/04: http://www.ahrq.gov/clinic/epcsums/o3lipidsum.pdf; current access available via PURL.